|
1
|
Gao X, Zhang S and Zhu Z: Lysyl oxidase
rs1800449 polymorphism and cancer risk among Asians: Evidence from
a meta-analysis and a case-control study of colorectal cancer. Mol
Genet Genomics. 290:23–28. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Abrams TA, Brightly R, Mao J, Kirkner G,
Meyerhardt JA, Schrag D and Fuchs CS: Patterns of adjuvant
chemotherapy use in a population-based cohort of patients with
resected stage II or III colon cancer. J Clin Oncol. 29:3255–3262.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Blarigan EV, Fuchs CS, Niedzwiecki D, Ye
X, Zhang S, Song M, Saltz L, Mayer RJ, Mowat RB, Whittom R, et al:
Long-chain omega-3 fatty acid and fish intake after colon cancer
diagnosis and disease-free, recurrence-free, and overall survival
in CALGB 89803 (Alliance). J Clin Oncol. 35:5852017. View Article : Google Scholar
|
|
4
|
Doi T, Ishikawa T, Okayama T, Oka K,
Mizushima K, Yasuda T, Sakamoto N, Katada K, Kamada K, Uchiyama K,
et al: The JAK/STAT pathway is involved in the upregulation of
PD-L1 expression in pancreatic cancer cell lines. Oncol Rep.
37:1545–1554. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Ren W, Shen S, Sun Z, Shu P, Shen X, Bu C,
Ai F, Zhang X, Tang A, Tian L, et al: Jak-STAT3 pathway triggers
DICER1 for proteasomal degradation by ubiquitin ligase complex of
CUL4A(DCAF1) to promote colon cancer development. Cancer Lett.
375:209–220. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Wang Z, Jin H, Xu R, Mei Q and Fan D:
Triptolide downregulates Rac1 and the JAK/STAT3 pathway and
inhibits colitis-related colon cancer progression. Exp Mol Med.
41:717–727. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Olsen J, Eiholm S, Kirkeby LT, Espersen
ML, Jess P, Gögenür I, Olsen J and Troelsen JT: CDX2 downregulation
is associated with poor differentiation and MMR deficiency in colon
cancer. Exp Mol Pathol. 100:59–66. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Zuo M, Li C, Lin J and Javle M: LLL12, a
novel small inhibitor targeting STAT3 for hepatocellular carcinoma
therapy. Oncotarget. 6:10940–10949. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Ouyang J, Pan X, Lin H, Hu Z, Xiao P and
Hu H: GKN2 increases apoptosis, reduces the proliferation and
invasion ability of gastric cancer cells through down-regulating
the JAK/STAT signaling pathway. Am J Transl Res. 9:803–811.
2017.PubMed/NCBI
|
|
10
|
Zheng XJ, Yang ZX, Dong YJ, Zhang GY, Sun
MF, An XK, Pan LH and Zhang SL: Downregulation of leptin inhibits
growth and induces apoptosis of lung cancer cells via the Notch and
JAK/STAT3 signaling pathways. Biol Open. 5:794–800. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Zhang Y, Meng X, Shi H, Li W, Ming Z,
Zhong Y, Deng W, Zhang Q, Fan N, Niu Z, et al: The role of
JAK/STAT3 signaling pathway on apoptosis of lung adenocarcinoma
cell line PC-9 induced by icotinib. Am J Transl Res. 8:1730–1737.
2016.PubMed/NCBI
|
|
12
|
Xue C, Xie J, Zhao D, Lin S, Zhou T, Shi
S, Shao X, Lin Y, Zhu B and Cai X: The JAK/STAT3 signalling pathway
regulated angiogenesis in an endothelial cell/adipose-derived
stromal cell co-culture, 3D gel model. Cell Prolif. 50:e123072017.
View Article : Google Scholar
|
|
13
|
Lei K, Tan S, Du W, Xu Y, Lin S, Zheng Y,
Zou F, Xu Y and Liu J: 3B, a novel photosensitizer, exhibits
anti-tumor effects via mitochondrial apoptosis pathway in MCF-7
human breast carcinoma cells. Tumour Biol. 36:5597–5606. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Lee JH, Kim C, Baek SH, Ko JH, Lee SG,
Yang WM, Um JY, Sethi G and Ahn KS: Capsazepine inhibits JAK/STAT3
signaling, tumor growth, and cell survival in prostate cancer.
Oncotarget. 8:17700–17711. 2017.PubMed/NCBI
|
|
15
|
Kumano K, Nakao A, Nakajima H, Miike S,
Kurasawa K, Saito Y and Iwamoto I: Blockade of JAK2 by tyrphostin
AG-490 inhibits antigen-induced eosinophil recruitment into the
mouse airways. Biochem Biophys Res Commun. 270:209–214. 2000.
View Article : Google Scholar : PubMed/NCBI
|
